New Treatment Developed by Children's Hospital of Philadelphia Shows Success in High-Risk Solid

Now, in a breakthrough study, researchers at Children's Hospital of Philadelphia (CHOP) have shown that an enhanced treatment developed in their lab leads to long-term remissions in 80% to 100% of mice with drug-resistant or high-risk solid tumors.

Read more: https://www.dailyamerican.com/news/state/new-treatment-developed-by-childrens-hospital-of-philadelphia-shows-success-in-high-risk-solid-tumors/article_ac6fad9c-ef39-5a8f-b4ae-ad71fa67979d.html